Special Anniversary Review: Twenty-five years of human immunodeficiency virus research: Successes and challenges

Clinical and Experimental Immunology

Volumn 152, Issue 2, 2008, Pages 201-210

  Weiss, R A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

AIDS; HIV; Immunopathogenesis; Therapy; Vaccine

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CELL GROWTH; HOST SUSCEPTIBILITY; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOGENESIS; MICROBIAL DIVERSITY; PRIORITY JOURNAL; REVIEW; SIMIAN IMMUNODEFICIENCY VIRUS;

AIDS VACCINES; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DISEASE SUSCEPTIBILITY; HEALTH PROMOTION; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HIV INFECTIONS; HIV-1; HIV-2; HUMANS;

EID: 42049119644     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2008.03645.x     Document Type: Review

References (90)

1. Barré-Sinoussi F, Chermann JC, Rey F et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983 220 : 868 71.
2. Levy JA. HIV and the pathogenesis of AIDS, 3rd edn. Washington, DC : American Society for Microbiology, 2007.
3. CDC. Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men - New York City and California. MMWR 1981 30 : 305 8.
4. Gottlieb MS, Schroff R, Schanker HM et al. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med 1981 305 : 1425 31.
5. Masur H, Michelis MA, Greene JB et al. An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. N Engl J Med 1981 305 : 1431 8.
6. CDC. Possible transfusion-associated acquired immune deficiency syndrome (AIDS) - California. MMWR 1982 31 : 652 4.
7. Ragni MV, Lewis JH, Spero JA, Bontempo FA. Acquired-immunodeficiency-like syndrome in two haemophiliacs. Lancet 1983 1 : 213 14.
8. Shilts R. And the band played on: politics, people and the AIDS epidemic. Stonewall Inn London, Penquin : Saint Martin's Press Inc., 1994.
9. Anonymous. The Durban declaration. Nature 2000 406 : 15 16.
10. AIDSTruth. 2008. Available at: http://www.aidstruth.org/
11. Nattrass N. Mortal combat: AIDS denialism and the struggle for antiretrovirals in South Africa. Durban : University of KwaZulu-Natal Press 2007.
12. Gelmann EP, Popovic M, Blayney D et al. Proviral DNA of a retrovirus, human T-cell leukemia virus, in two patients with AIDS. Science 1983 220 : 862 5.
13. Essex M, McLane MF, Lee TH et al. Antibodies to cell membrane antigens associated with human T-cell leukemia virus in patients with AIDS. Science 1983 220 : 859 62.
14. Vilmer E, Barré-Sinoussi F, Rouzioux C et al. Isolation of new lymphotropic retrovirus from two siblings with haemophilia B, one with AIDS. Lancet 1984 1 : 753 7.
15. Montagnier L, Dauguet C, Axler C et al. A new type of retrovirus isolated from patients presenting with lymphadenopathy and acquired immune deficiency syndrome: structural and antigenic relatedness with equine infectious anaemia virus. Ann Virol 1984 135E : 119 34.
16. Wain Hobson S, Sonigo P, Danos O, Cole S, Alizon M. Nucleotide sequence of the AIDS virus, LAV. Cell 1985 40 : 9 17.
17. Sonigo P, Alizon M, Staskus K et al. Nucleotide sequence of the visna lentivirus: relationship to the AIDS virus. Cell 1985 42 : 369 82.
18. Popovic M, Sarngadharan MG, Read E, Gallo RC. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 1984 224 : 497 500.
19. Levy JA, Hoffman AD, Kramer SM, Landis JA, Shimabukuro JM, Oshiro LS. Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Science 1984 225 : 840 2.
20. Wain-Hobson S, Vartanian JP, Henry M et al. LAV revisited: origins of the early HIV-1 isolates from Institut Pasteur. Science 1991 252 : 961 5.
21. Coffin J, Haase A, Levy JA et al. Human immunodeficiency viruses. Science 1986 232 : 697.
22. Cheingsong-Popov R, Weiss RA, Dalgleish A et al. Prevalence of antibody to human T-lymphotropic virus type III in AIDS and AIDS-risk patients in Britain. Lancet 1984 2 : 477 80.
23. Piot P, Quinn TC, Taelman H et al. Acquired immunodeficiency syndrome in a heterosexual population in Zaire. Lancet 1984 2 : 65 9.
24. Van de Perre P, Rouvroy D, Lepage P et al. Acquired immunodeficiency syndrome in Rwanda. Lancet 1984 2 : 62 5.
25. Ellrodt A, Barre-Sinoussi F, Le Bras P et al. Isolation of human T-lymphotropic retrovirus (LAV) from Zairian married couple, one with AIDS, one with prodromes. Lancet 1984 1 : 1383 5.
26. Bayley AC, Downing RG, Cheingsong-Popov R, Tedder RS, Dalgleish AG, Weiss RA. HTLV-III serology distinguishes atypical and endemic Kaposi's sarcoma in Africa. Lancet 1985 1 : 359 61.
27. Serwadda D, Mugerwa RD, Sewankambo NK et al. Slim disease: a new disease in Uganda and its association with HTLV-III infection. Lancet 1985 2 : 849 52.
28. UNAIDS. 2007. Available at: http://www.unaids.org/en/KnowledgeCentre/ HIVData/EpiUpdate/EpiUpdArchive/2007/default.asp
29. Daniel MD, Letvin NL, King NW et al. Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. Science 1985 228 : 1201 4.
30. Keele BF, Van Heuverswyn F, Li Y et al. Chimpanzee reservoirs of pandemic and nonpandemic HIV-1. Science 2006 313 : 523 6.
31. Van Heuverswyn F, Li Y, Neel C et al. Human immunodeficiency viruses: SIV infection in wild gorillas. Nature 2006 444 : 164.
32. Heeney JL, Dalgleish AG, Weiss RA. Origins of HIV and the evolution of resistance to AIDS. Science 2006 313 : 462 6.
33. Barin F, M'Boup S, Denis F et al. Serological evidence for virus related to simian T-lymphotropic retrovirus III in residents of west Africa. Lancet 1985 2 : 1387 9.
34. Clavel F, Guetard D, Brun Vezinet F et al. Isolation of a new human retrovirus from West African patients with AIDS. Science 1986 233 : 343 6.
35. Leligdowicz A, Yindom LM, Onyango C et al. Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection. J Clin Invest 2007 117 : 3067 74.
36. Korber B, Gaschen B, Yusim K et al. Evolutionary and immunological implications of contemporary HIV-1 variation. In : Weiss RA Adler M A, Rowland-Jones SL, eds. The changing face of HIV and AIDS. Oxford : Oxford University Press, 2001 : 19 42.
37. Aboulker JP, Swart AM. Preliminary analysis of the Concorde trial. Concorde Coordinating Committee. Lancet 1993 341 : 889 990.
38. Hicks CB, Gay C, Ferrari G. Acute HIV infection: the impact of anti-retroviral treatment on cellular immune responses. Clin Exp Immunol 2007 149 : 211 16.
39. Van de Perre P, Segondy P, Foulongne V et al. Herpes simplex virus and human immunodeficiency virus: deciphering a deadly synergy. Lancet Infect Dis 2008 in press.
40. Weiss HA, Quigley MA, Hayes RJ. Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis. AIDS 2000 14 : 2361 70.
41. Patterson BK, Landay A, Siegel JN et al. Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in explant culture. Am J Pathol 2002 161 : 867 73.
42. Weiss HA. Male circumcision as a preventive measure against HIV and other sexually transmitted diseases. Curr Opin Infect Dis 2007 20 : 66 72.
43. Klasse PJ, Shattock R, Moore JP. Antiretroviral drug-based microbicides to prevent HIV-1 sexual transmission. Annu Rev Med 2008 59 : 455 71.
44. Klatzmann D, Barre Sinoussi F, Nugeyre MT et al. Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes. Science 1984 225 : 59 63.
45. Klatzmann D, Champagne E, Chamaret S et al. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 1984 312 : 767 8.
46. Dalgleish AG, Beverley PC, Clapham PR, Crawford DH, Greaves MF, Weiss RA. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 1984 312 : 763 7.
47. Maddon PJ, Dalgleish AG, McDougal JS, Clapham PR, Weiss RA, Axel R. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 1986 47 : 333 48.
48. Cocchi F, DeVico AL, Garzino Demo A, Arya SK, Gallo RC, Lusso P. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995 270 : 1811 15.
49. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996 272 : 872 7.
50. Alkhatib G, Combadiere C, Broder CC et al. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996 272 : 1955 8.
51. Gartner S, Markovits P, Markovitz DM, Kaplan MH, Gallo RC, Popovic M. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 1986 233 : 215 19.
52. Fassati A. HIV infection of non-dividing cells: a divisive problem. Retrovirology 2006 3 : 74.
53. Ryan S, Tiley L, McConnell I, Blacklaws B. Infection of dendritic cells by the Maedi-Visna lentivirus. J Virol 2000 74 : 10096 103.
54. Knight SC, Macatonia SE. Dendritic cells and viruses. Immunol Lett 1988 19 : 177 81.
55. Piguet V, Steinman RM. The interaction of HIV with dendritic cells: outcomes and pathways. Trends Immunol 2007 28 : 503 10.
56. Patterson S, Rae A, Hockey N, Gilmour J, Gotch F. Plasmacytoid dendritic cells are highly susceptible to human immunodeficiency virus type 1 infection and release infectious virus. J Virol 2001 75 : 6710 13.
57. Jolly C, Kashefi K, Hollinshead M, Sattentau QJ. HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse. J Exp Med 2004 199 : 283 93.
58. Weiss RA. How does HIV cause AIDS? Science 1993 260 : 1273 9.
59. Mellors JW, Munoz A, Giorgi JV et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997 126 : 946 54.
60. Pantaleo G, Graziosi C, Demarest JF et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993 362 : 355 8.
61. Tenner-Racz K, Racz P, Dietrich M, Kern P. Altered follicular dendritic cells and virus-like particles in AIDS and AIDS-related lymphadenopathy. Lancet 1985 1 : 105 6.
62. Haase AT. Perils at mucosal front lines for HIV and SIV and their hosts. Nat Rev Immunol 2005 5 : 783 92.
63. Stebbing J, Gazzard B, Douek DC. Where does HIV live? N Engl J Med 2004 350 : 1872 80.
64. Walker BD. Elite control of HIV infection: implications for vaccines and treatment. Top HIV Med 2007 15 : 134 6.
65. Aasa-Chapman MM, Holuigue S, Aubin K et al. Detection of antibody-dependent complement-mediated inactivation of both autologous and heterologous virus in primary human immunodeficiency virus type 1 infection. J Virol 2005 79 : 2823 30.
66. Huber M, Fischer M, Misselwitz B et al. Complement lysis activity in autologous plasma is associated with lower viral loads during the acute phase of HIV-1 infection. PLoS Med 2006 3 : e441.
67. Brenchley JM, Price DA, Douek DC. HIV disease: fallout from a mucosal catastrophe? Nat Immunol 2006 7 : 235 9.
68. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995 373 : 123 6.
69. Wei X, Ghosh SK, Taylor ME et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995 373 : 117 22.
70. Wu H, Zhu H, Miao H, Perelson AS. Parameter identifiability and estimation of HIV/AIDS dynamic models. Bull Math Biol 2008 doi: 10.1007/s11538-007-9279-9.
71. Deayton JR, Sabin CA, Johnson MA, Emery VC, Wilson P, Griffiths PD. Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy. Lancet 2004 363 : 2116 21.
72. Cadogan M, Austen B, Heeney JL, Dalgleish AG. HLA homology within the C5 domain promotes peptide binding by HIV-1 gp120. AIDS Res Hum Retroviruses 2008 in press.
73. Carrington M, O'Brien SJ. The influence of HLA genotype on AIDS. Annu Rev Med 2003 54 : 535 51.
74. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 2004 427 : 848 53.
75. Towers GJ. The control of viral infection by tripartite motif proteins and cyclophilin A. Retrovirology 2007 4 : 40.
76. Sawyer SL, Wu LI, Akey JM, Emerman M, Malik HS. High-frequency persistence of an impaired allele of the retroviral defense gene TRIM5alpha in humans. Curr Biol 2006 16 : 95 100.
77. Goldschmidt V, Bleiber G, May M, Martinez R, Ortiz M, Telenti A. Role of common human TRIM5alpha variants in HIV-1 disease progression. Retrovirology 2006 3 : 54.
78. Holmes RK, Malim MH, Bishop KN. APOBEC-mediated viral restriction: not simply editing? Trends Biochem Sci 2007 32 : 118 28.
79. Fellay J, Shianna KV, Ge D et al. A whole-genome association study of major determinants for host control of HIV-1. Science 2007 317 : 944 7.
80. Colobran R, Pujol-Borrell R, Armengol MP, Juan M. The chemokine network. II. On how polymorphisms and alternative splicing increase the number of molecular species and configure intricate patterns of disease susceptibility. Clin Exp Immunol 2007 150 : 1 12.
81. Liu R, Paxton WA, Choe S et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996 86 : 367 77.
82. Gonzalez E, Kulkarni H, Bolivar H et al. The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science 2005 307 : 1434 40.
83. Gilbert PB, Peterson ML, Follmann D et al. Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial. J Infect Dis 2005 191 : 666 77.
84. Anonymous. HIV vaccine failure prompts Merck to halt trial. Nature 2007 449 : 390.
85. Mascola JR, Stiegler G, VanCott TC et al. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat Med 2000 6 : 207 10.
86. Stott J, Hu SL, Almond N. Candidate vaccines protect macaques against primate immunodeficiency viruses. AIDS Res Hum Retroviruses 1998 14 (Suppl. 3 S265 70.
87. Wyand MS, Manson K, Montefiori DC, Lifson JD, Johnson RP, Desrosiers RC. Protection by live, attenuated simian immunodeficiency virus against heterologous challenge. J Virol 1999 73 : 8356 63.
88. Fowke KR, Dong T, Rowland-Jones SL et al. HIV type 1 resistance in Kenyan sex workers is not associated with altered cellular susceptibility to HIV type 1 infection or enhanced beta-chemokine production. AIDS Res Hum Retroviruses 1998 14 : 1521 30.
89. Garber DA, Silvestri G, Feinberg MB. Prospects for an AIDS vaccine: three big questions, no easy answers. Lancet Infect Dis 2004 4 : 397 413.
90. Zhou T, Xu L, Dey B et al. Structural definition of a conserved neutralization epitope on HIV-1 gp120. Nature 2007 445 : 732 7.